(1 - 36 from 57
)
First-line nivolumab-ipilimumab combination improves OS in ...
www.healio.com
Aug 10, — Paul Baas, MD, researcher at Netherlands Cancer Institute and University of Leiden in Amsterdam, presented the results during the ... › news › hematology-oncology
World Lung – Bristol delivers on its mesothelioma promise
www.evaluate.com
Aug 10, — The first-line trial positions Opdivo plus Yervoy to become a new standard of care, said Netherlands Cancer Institute's Dr Paul Baas, ... › events › conferences › worl...
sorted by relevance / date